|
1
|
McGlynn KA, Petrick JL and London WT:
Global epidemiology of hepatocellular carcinoma: An emphasis on
demographic and regional variability. Clin Liver Dis. 19:223–238.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Korean Liver Cancer Association, National
Cancer Center, . 2018 Korean Liver Cancer Association-National
Cancer Center Korea Practice Guidelines for the Management of
Hepatocellular Carcinoma. Gut Liver. 13:227–299. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Liu J, Lv Y, Zhang C and Guo S:
lncRNA meg3 suppresses hepatocellular carcinoma in vitro and vivo
studies. Am J Transl Res. 11:4089–4099. 2019.PubMed/NCBI
|
|
7
|
Zhuo H, Tang J, Lin Z, Jiang R, Zhang X,
Ji J, Wang P and Sun B: The aberrant expression of MEG3 regulated
by UHRF1 predicts the prognosis of hepatocellular carcinoma. Mol
Carcinog. 55:209–219. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu F, Yang Z and Li G: Role of specific
microRNAs for endothelial function and angiogenesis. Biochem
Biophys Res Commun. 386:549–553. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lopez-Urrutia E, Bustamante Montes LP,
Ladron de Guevara Cervantes D, Perez-Plasencia C and Campos-Parra
AD: Crosstalk between long non-coding RNAs, Micro-RNAs and mRNAs:
Deciphering molecular mechanisms of master regulators in cancer.
Front Oncol. 9:6692019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tam C, Wong JH, Tsui SKW, Zuo T, Chan TF
and Ng TB: lncRNAs with miRNAs in regulation of gastric, liver, and
colorectal cancers: Updates in recent years. Appl Microbiol
Biotechnol. 103:4649–4677. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Snezhkina AV, Krasnov GS, Zhikrivetskaya
SO, Karpova IY, Fedorova MS, Nyushko KM, Belyakov MM, Gnuchev NV,
Sidorov DV, Alekseev BY, et al: Overexpression of microRNAs miR-9,
−98, and −199 correlates with the downregulation of HK2 expression
in colorectal cancer. Mol Biol (Mosk). 52:220–230. 2018.(In
Russian). View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou L, Fu L, Lv N, Chen XS, Liu J, Li Y,
Xu QY, Huang S, Zhang XD, Dou LP, et al: A minicircuitry comprised
of microRNA-9 and SIRT1 contributes to leukemogenesis in t(8;21)
acute myeloid leukemia. Eur Rev Med Pharmacol Sci. 21:786–794.
2017.PubMed/NCBI
|
|
14
|
Tsai KW, Liao YL, Wu CW, Hu LY, Li SC,
Chan WC, Ho MR, Lai CH, Kao HW, Fang WL, et al: Aberrant
hypermethylation of miR-9 genes in gastric cancer. Epigenetics.
6:1189–1197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu M, Huang Y, Chen T, Wang W, Yang S, Ye
Z and Xi X: lncRNA MEG3 inhibits the progression of prostate cancer
by modulating miR-9-5p/QKI-5 axis. J Cell Mol Med. 23:29–38. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong Z, Zhang A, Liu S, Lu F, Guo Y, Zhang
G, Xu F, Shi Y, Shen S, Liang J and Guo W: Aberrant
methylation-mediated silencing of lncRNA MEG3 functions as a ceRNA
in esophageal cancer. Mol Cancer Res. 15:800–810. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kretschmer PJ, Fairhurst JL, Decker MM,
Chan CP, Gluzman Y, Böhlen P and Kovesdi I: Cloning,
characterization and developmental regulation of two members of a
novel human gene family of neurite outgrowth-promoting proteins.
Growth Factors. 5:99–114. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Filippou PS, Karagiannis GS and
Constantinidou A: Midkine (MDK) growth factor: A key player in
cancer progression and a promising therapeutic target. Oncogene.
39:2040–2054. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang F, Shan S, Huo Y, Xie Z, Fang Y, Qi
Z, Chen F, Li Y and Sun B: miR-155-5p inhibits PDK1 and promotes
autophagy via the mTOR pathway in cervical cancer. Int J Biochem
Cell Biol. 99:91–99. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng F, Zhang Y, Li X, Wang J and Wang Z:
Clinical significance of miR-138 in patients with malignant
melanoma through targeting of PDK1 in the PI3K/AKT autophagy
signaling pathway. Oncol Rep. 38:1655–1662. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chuang CK, Lin HCA, Tasi HY, Lee KH, Kao
Y, Chuang FL, Chang YH, Lin PH, Liu CY and Pang ST: Clinical
presentations and molecular studies of invasive renal epithelioid
angiomyolipoma. Int Urol Nephrol. 49:1527–1536. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu J, Liu QH, Wang F, Tan JJ, Deng YQ,
Peng XH, Liu X, Zhang B, Xu X and Li XP: Exosomal miR-9 inhibits
angiogenesis by targeting MDK and regulating PDK/AKT pathway in
nasopharyngeal carcinoma. J Exp Clin Cancer Res. 37:1472018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abbastabar M, Sarfi M, Golestani A and
Khalili E: lncRNA involvement in hepatocellular carcinoma
metastasis and prognosis. EXCLI J. 17:900–913. 2018.PubMed/NCBI
|
|
25
|
Huang Z, Zhou JK, Peng Y, He W and Huang
C: The role of long noncoding RNAs in hepatocellular carcinoma. Mol
Cancer. 19:772020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei GH and Wang X: lncRNA MEG3 inhibit
proliferation and metastasis of gastric cancer via p53 signaling
pathway. Eur Rev Med Pharmacol Sci. 21:3850–3856. 2017.PubMed/NCBI
|
|
27
|
Zhang CY, Yu MS, Li X, Zhang Z, Han CR and
Yan B: Overexpression of long non-coding RNA MEG3 suppresses breast
cancer cell proliferation, invasion, and angiogenesis through AKT
pathway. Tumour Biol. 39:10104283177013112017.PubMed/NCBI
|
|
28
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He JH, Han ZP, Liu JM, Zhou JB, Zou MX, Lv
YB, Li YG and Cao MR: Overexpression of long non-coding RNA meg3
inhibits proliferation of hepatocellular carcinoma Huh7 Cells via
negative modulation of miRNA-664. J Cell Biochem. 118:3713–3721.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu H, Zhou Y and Tang L: Caffeine induces
sustained apoptosis of human gastric cancer cells by activating the
caspase-9/caspase-3 signalling pathway. Mol Med Rep. 16:2445–2454.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Altadill A, Rodríguez M, González LO,
Junquera S, Corte MD, González-Dieguez ML, Linares A, Barbón E,
Fresno-Forcelledo M, Rodrigo L and Vizoso FJ: Liver expression of
matrix metalloproteases and their inhibitors in hepatocellular
carcinoma. Dig Liver Dis. 41:740–748. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Veneziano D, Marceca GP, Di Bella S,
Nigita G, Distefano R and Croce CM: Investigating miRNA-lncRNA
interactions: Computational tools and resources. Methods Mol Biol.
1970:251–277. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang X, Su R, Guo Q, Liu J, Ruan B and
Wang G: Competing endogenous RNA (ceRNA) hypothetic model based on
comprehensive analysis of long non-coding RNA expression in lung
adenocarcinoma. PeerJ. 7:e80242019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang Y: The novel regulatory role of
lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med.
22:5768–5775. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen K, Ma Y, Wu S, Zhuang Y, Liu X, Lv L
and Zhang G: Construction and analysis of a lncRNA-miRNA-mRNA
network based on competitive endogenous RNA reveals functional
lncRNAs in diabetic cardiomyopathy. Mol Med Rep. 20:1393–1403.
2019.PubMed/NCBI
|
|
36
|
Zhu D, Xiao Z, Wang Z, Hu B, Duan C, Zhu
Z, Gao N, Zhu Y and Wang H: MEG3/MIR-376B-3P/HMGA2 axis is involved
in pituitary tumor invasiveness. J Neurosurg. 2020.(Ahead of
print).
|
|
37
|
Lu WX: Long non-coding RNA MEG3 represses
cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis. Eur Rev Med
Pharmacol Sci. 23:7356–7368. 2019.PubMed/NCBI
|
|
38
|
Zhang S and Guo W: Long non-coding RNA
MEG3 suppresses the growth of glioma cells by regulating the
miR-96-5p/MTSS1 signaling pathway. Mol Med Rep. 20:4215–4225.
2019.PubMed/NCBI
|
|
39
|
Shen X, Bai H, Zhu H, Yan Q, Yang Y, Yu W,
Shi Q, Wang J, Li J and Chen L: Long non-coding RNA MEG3 functions
as a competing endogenous RNA to regulate HOXA11 expression by
sponging miR-181a in multiple myeloma. Cell Physiol Biochem.
49:87–100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Z, Chen JY, Zhong Y, Xie L and Li JS:
lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells
by sponging miR-9-5p to upregulate SOX11. Braz J Med Biol Res.
52:e86312019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li XY, Wen JY, Jia CC, Wang TT, Li X, Dong
M, Lin QU, Chen ZH, Ma XK, Wei LI, et al: MicroRNA-34a-5p enhances
sensitivity to chemotherapy by targeting AXL in hepatocellular
carcinoma MHCC-97L cells. Oncol Lett. 10:2691–2698. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kai AK, Chan LK, Lo RC, Lee JM, Wong CC,
Wong JC and Ng IO: Down-regulation of TIMP2 by
HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer
metastasis in hepatocellular carcinoma. Hepatology. 64:473–487.
2016. View Article : Google Scholar : PubMed/NCBI
|
